扩展性中膜切除术(EMMR):基于个体发育癌场理论治疗局部晚期宫颈癌的手术入路
基于个体发育解剖学理论,研究者开展前瞻性单中心研究,评估扩展性中膜切除术(EMMR)联合治疗性淋巴结清扫用于术中评估宫颈癌固定于膀胱和/或膀胱系膜患者的可行性。48例连续入组患者中位肿瘤大小5cm,85%存在淋巴结转移,全部实现R0切除,5年无复发生存率54.1%(95%CI 38.3-69.9),5年总生存率62.6%(95%CI 45.6-79.6),结论为EMMR在此类患者中可行且无需术后辅助放疗。
要点
- 48例局部晚期宫颈癌患者接受EMMR联合治疗性淋巴结清扫,均未行术后辅助放疗。
- 全部患者实现R0切除,5年无复发生存率54.1%(95%CI 38.3-69.9),5年总生存率62.6%(95%CI 45.6-79.6)。
- 围手术期II级和III级并发症分别发生于25%和15%的患者。
核心结论
- EMMR作为局部晚期宫颈癌伴区域淋巴结侵犯患者的手术治疗方式具有可行性,且无需术后辅助放疗。
研究设计与样本
- 前瞻性单中心研究,评估EMMR联合治疗性淋巴结清扫用于术中评估宫颈癌固定于膀胱和/或膀胱系膜患者的可行性。
- 连续入组48例患者,均未接受术后辅助放疗。
- 中位肿瘤大小5cm,85%的患者存在淋巴结转移。
主要发现
- 全部病例实现完整肿瘤切除(R0)。
- 5年无复发生存率为54.1%(95%CI 38.3-69.9)。
- 5年总生存率为62.6%(95%CI 45.6-79.6)。
- 围手术期II级并发症发生于25%的患者,III级并发症发生于15%的患者(按Franco-Italian glossary判定)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Based on ontogenetic-anatomic considerations, we have introduced total mesometrial resection (TMMR) and laterally extended endopelvic resection (LEER) as surgical treatments for patients with cancer of the uterine cervix FIGO stages I B1 - IV A. For a subset of patients with locally advanced disease we have sought to develop an operative strategy characterized by the resection of additional tissue at risk for tumor infiltration as compared to TMMR, but less than in LEER, preserving the urinary bladder function. METHODS: We conducted a prospective single center study to evaluate the feasibility of extended mesometrial resection (EMMR) and therapeutic lymph node dissection as a surgical treatment approach for patients with cervical cancer fixed to the urinary bladder and/or its mesenteries as determined by intraoperative evaluation. None of the patients received postoperative adjuvant radiotherapy. RESULTS: 48 consecutive patients were accrued into the trial. Median tumor size was 5cm, and 85% of all patients were found to have lymph node metastases. Complete tumor resection (R0) was achieved in all cases. Recurrence free survival at 5years was 54.1% (95% CI 38.3-69.9). The overall survival rate was 62.6% (95% CI 45.6-79.6) at 5years. Perioperative morbidity represented by grade II and III complications (determined by the Franco-Italian glossary) occurred in 25% and 15% of patients, respectively. CONCLUSION: We demonstrate in this study the feasibility of EMMR as a surgical treatment approach for patients with locally advanced cervical cancer and regional lymph node invasion without the necessity for postoperative adjuvant radiation.
引用
- Wolf B, Ganzer R, Stolzenburg JU, et al. Extended mesometrial resection (EMMR): Surgical approach to the treatment of locally advanced cervical cancer based on the theory of ontogenetic cancer fields. Gynecol Oncol. 2017. PMID: 28526168. doi:10.1016/j.ygyno.2017.05.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。